Biomedicines MDPI

Biomedicines MDPI is a leading international, peer-reviewed, open-access journal focused on biomedicines, published monthly online. Dedicated to advancing research on human health and disease, Biomedicines MDPI covers the discovery and characterization of new therapeutic targets, innovative therapeutic strategies, and the exploration of naturally derived biomedicines, pharmaceuticals, and biopharmaceutical products. The journal's commitment to high-quality research makes it an essential resource for scientists and researchers worldwide.

Located at St. Alban-Anlage 66, Basel, 4052, CH, Biomedicines MDPI addresses critical topics, including pathogenesis mechanisms of diseases, translational medical research, and the use of biomaterials in biomedical research. It also explores novel targets in various therapeutic areas such as cardiovascular, oncology, neurology, and dermatology, along with biomarker discovery and early diagnosis research. Biomedicines MDPI consistently publishes papers that tackle the challenges of bringing biological agents and novel targeted strategies from the laboratory to clinical application.

Biomedicines MDPI remains at the forefront of biomedical publishing, covering areas such as drug discovery and development, biopharmaceutical biomedicines (including biologics and biosimilars), and nanobiotechnological advancements. The journal is a vital platform for sharing the latest breakthroughs in areas like nanomedicine, biosensors, gene therapy, and tissue engineering. The team at Biomedicines MDPI looks forward to including your important contributions in upcoming issues. To the manager of Biomedicines MDPI, we invite you to create a customized and exclusive company showcase and product listing on our platform to further enhance your visibility and reach.